Cyclophosphamide as a Treatment for Focal Segmental Glomerular Sclerosis Recurrence in a Kidney Transplant Patient

Mariann H. Al-Jehani; Faisal Al-Husayni; Abdullah Aljabri; Hatim Qasim AlMaghraby; Turki A. Banamah

doi:10.12659/AJCR.929097

04 February 2021 : Case report Saudi Arabia

Cyclophosphamide as a Treatment for Focal Segmental Glomerular Sclerosis Recurrence in a Kidney Transplant Patient

Unusual or unexpected effect of treatment

Mariann H. Al-Jehani^1E, Faisal Al-Husayni^23A, Abdullah Aljabri^23B, Hatim Qasim AlMaghraby^145BD, Turki A. Banamah^167EF*

DOI: 10.12659/AJCR.929097

Am J Case Rep 2021; 22:e929097

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 4. Timeline of FSGS disease, relapses, and medication regimen. FSGS: focal segmental glomerulosclerosis. PD – peritoneal dialysis; MMF – mycophenolic acid; IVIG – intravenous immunoglobulin.

Back to the Article

Cyclophosphamide as a Treatment for Focal Segmental Glomerular Sclerosis Recurrence in a Kidney Transplant Patient

Your Privacy